Paying users zone. Data is covered by 
.
Get to Eli Lilly & Co. for $17.99, or
get to whole website for at least 3 months from $49.99.
Debt to Equity
since 2005
Difficulty: Beginner
Calculation
Eli Lilly & Co., debt to equity, long-term trends, calculation
| Debt to Equity | = | Total debt1 | ÷ | Total Eli Lilly and Company shareholders' equity1 | |
|---|---|---|---|---|---|
| Dec 31, 2005 | |
= | |
÷ | |
| Dec 31, 2006 | |
= | |
÷ | |
| Dec 31, 2007 | |
= | |
÷ | |
| Dec 31, 2008 | |
= | |
÷ | |
| Dec 31, 2009 | |
= | |
÷ | |
| Dec 31, 2010 | |
= | |
÷ | |
| Dec 31, 2011 | |
= | |
÷ | |
| Dec 31, 2012 | |
= | |
÷ | |
| Dec 31, 2013 | |
= | |
÷ | |
| Dec 31, 2014 | |
= | |
÷ | |
| Dec 31, 2015 | |
= | |
÷ | |
| Dec 31, 2016 | |
= | |
÷ | |
| Dec 31, 2017 | |
= | |
÷ | |
1 USD $ in thousands
Source: Based on data from Eli Lilly & Co. Annual Reports
Comparison to Competitors
Eli Lilly & Co., debt to equity, long-term trends, comparison to competitors
| Eli Lilly & Co. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Amgen Inc. | Biogen Inc. | Bristol-Myers Squibb Co. | Celgene Corp. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2005 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2006 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2007 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2008 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2009 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2010 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2011 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2012 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2013 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2014 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2015 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2016 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2017 | |
|
|
|
|
|
|
|
|
|
|
|
|
Source: Based on data from Eli Lilly & Co. Annual Reports
Comparison to Pharmaceuticals & Biotechnology Sector
Eli Lilly & Co., debt to equity, long-term trends, comparison to Pharmaceuticals & Biotechnology sector
| Eli Lilly & Co. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2005 | |
|
| Dec 31, 2006 | |
|
| Dec 31, 2007 | |
|
| Dec 31, 2008 | |
|
| Dec 31, 2009 | |
|
| Dec 31, 2010 | |
|
| Dec 31, 2011 | |
|
| Dec 31, 2012 | |
|
| Dec 31, 2013 | |
|
| Dec 31, 2014 | |
|
| Dec 31, 2015 | |
|
| Dec 31, 2016 | |
|
| Dec 31, 2017 | |
|
Source: Based on data from Eli Lilly & Co. Annual Reports
Comparison to Health Care Industry
Eli Lilly & Co., debt to equity, long-term trends, comparison to Health Care industry
| Eli Lilly & Co. | Health Care | |
|---|---|---|
| Dec 31, 2005 | |
|
| Dec 31, 2006 | |
|
| Dec 31, 2007 | |
|
| Dec 31, 2008 | |
|
| Dec 31, 2009 | |
|
| Dec 31, 2010 | |
|
| Dec 31, 2011 | |
|
| Dec 31, 2012 | |
|
| Dec 31, 2013 | |
|
| Dec 31, 2014 | |
|
| Dec 31, 2015 | |
|
| Dec 31, 2016 | |
|
| Dec 31, 2017 | |
|
Source: Based on data from Eli Lilly & Co. Annual Reports
